BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 33114351)

  • 1. Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells.
    Kandarakov O; Belyavsky A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease.
    Li J; Wang C; Liu J; Yu Y; Liu Y; Peng Q; Liu H; Guan X
    Mol Biol Rep; 2021 Apr; 48(4):3785-3798. PubMed ID: 33987748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Disease, Aging, and Clonal Hematopoiesis.
    Evans MA; Sano S; Walsh K
    Annu Rev Pathol; 2020 Jan; 15():419-438. PubMed ID: 31689371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
    Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
    J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors.
    Fuster JJ
    Thromb Res; 2022 May; 213 Suppl 1():S107-S112. PubMed ID: 36210552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis.
    Polizio AH; Park E; Walsh K
    Curr Atheroscler Rep; 2023 Mar; 25(3):105-111. PubMed ID: 36808603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
    Haybar H; Shahrabi S; Ghanavat M; Khodadi E
    J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis.
    Heyde A; Rohde D; McAlpine CS; Zhang S; Hoyer FF; Gerold JM; Cheek D; Iwamoto Y; Schloss MJ; Vandoorne K; Iborra-Egea O; Muñoz-Guijosa C; Bayes-Genis A; Reiter JG; Craig M; Swirski FK; Nahrendorf M; Nowak MA; Naxerova K
    Cell; 2021 Mar; 184(5):1348-1361.e22. PubMed ID: 33636128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis, somatic mosaicism, and age-associated disease.
    Evans MA; Walsh K
    Physiol Rev; 2023 Jan; 103(1):649-716. PubMed ID: 36049115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis and vascular disease.
    Amancherla K; Wells JA; Bick AG
    Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis: Pre-cancer PLUS.
    Silver AJ; Jaiswal S
    Adv Cancer Res; 2019; 141():85-128. PubMed ID: 30691686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis, aging, and cardiovascular diseases.
    Pardali E; Dimmeler S; Zeiher AM; Rieger MA
    Exp Hematol; 2020 Mar; 83():95-104. PubMed ID: 31891750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
    Fuster JJ; Walsh K
    Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.